Dihydrostreptomycin is an aminoglycoside antibiotic. In humans, the use of dihydrostreptomycin has been associated with ototoxicity. The FDA withdrew its approval for the use of all drug products containing dihydrostreptomycin sulfate. It is grouped under the following drug class(es): Aminoglycosides. The directory classifies it as a commercial API with a fermentation-derived source/manufacturing origin. Other names for this substance include Abiocine and Vibriomycin. Its PubChem CID is 439369.
Dihydrostreptomycin
| CAS No | 128-46-1 |
|---|---|
| Molecular Formula | C21H41N7O12 |
| Molecular Weight | 583.6 g/mol |
| Synonyms | 2-[(1R,2R,3S,4R,5R,6S)-3-(diaminomethylideneamino)-4-[(2R,3R,4R,5S)-3-[(2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-hydroxy-4-(hydroxymethyl)-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Dihydrostreptomycin is an aminoglycoside antibiotic. In humans, the use of dihydrostreptomycin has been associated with ototoxicity. The FDA withdrew its approval for the use of all drug products containing dihydrostreptomycin sulfate.
The listed CAS number is 128-46-1.
The listed molecular formula is C21H41N7O12.
The listed molecular weight is 583.6 g/mol.
2-[(1R,2R,3S,4R,5R,6S)-3-(diaminomethylideneamino)-4-[(2R,3R,4R,5S)-3-[(2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-hydroxy-4-(hydroxymethyl)-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine.
The source lists Abiocine and Vibriomycin.